NewEdge Advisors’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,535
| Closed | -$2.59K | – | 3808 |
|
|
2024
Q2 | $2.59K | Hold |
2,535
| – | – | ﹤0.01% | 3284 |
|
|
2024
Q1 | $4.64K | Hold |
2,535
| – | – | ﹤0.01% | 3158 |
|
|
2023
Q4 | $3.14K | Hold |
2,535
| – | – | ﹤0.01% | 3249 |
|
|
2023
Q3 | $2.89K | Hold |
2,535
| – | – | ﹤0.01% | 2964 |
|
|
2023
Q2 | $2.32K | Sell |
2,535
-800
| -24% | -$732 | ﹤0.01% | 3049 |
|
|
2023
Q1 | $1.87K | Hold |
3,335
| – | – | ﹤0.01% | 3047 |
|
|
2022
Q4 | $2 | Buy |
+3,335
| New | +$2 | ﹤0.01% | 3923 |
|